A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors.

Схожие документы

• ATP-Dependent Removal of Nucleoside Reverse Transcriptase Inhibitors by Human Immunodeficiency Virus Type 1 Reverse Transcriptase
  по: Naeger, Lisa K., et al.
  Опубликовано: (2002)
• Molecular Mechanism by Which the K70E Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Resistance to Nucleoside Reverse Transcriptase Inhibitors
  по: Sluis-Cremer, Nicolas, et al.
  Опубликовано: (2007)
• Impact of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Drug Resistance Mutation Interactions on Phenotypic Susceptibility
  по: Trivedi, Vinod, et al.
  Опубликовано: (2008)
• Subunit-Specific Analysis of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase In Vivo
  по: Mulky, Alok, et al.
  Опубликовано: (2004)
• Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates.
  по: Mellors, J W, et al.
  Опубликовано: (1995)